title: Olanzapine induced neuroleptic malignant syndrome.
abstract: An 18 year old male diagnosed as a case of bipolar affective disorder (BPAD), developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. NMS is usually seen with typical antipsychotic drugs. The patient was diagnosed as a case of NMS, offending agent was immediately withdrawn and prompt treatment with bromocriptine and levodopa produced a good recovery. The various features of the case are discussed in view of the potential mortality of the syndrome.
authors.affiliation: Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
authors.forename: Bichitra Nanda
authors.initials: BN
authors.lastname: Patra
authors.forename: Sudhir K
authors.initials: SK
authors.lastname: Khandelwal
authors.forename: Mamta
authors.initials: M
authors.lastname: Sood
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine
keywords: Bipolar affective disorder; Neuroleptic malignant syndrome; olanzapine
references.citation: Am J Hosp Pharm. 1992 Sep;49(9):2229-32
references.pmid: 1524068
references.citation: Encephale. 2008 Dec;34(6):618-24
references.pmid: 19081460
references.citation: Indian J Psychiatry. 2009 Jul-Sep;51(3):202-5
references.pmid: 19881049
references.citation: Clin Pharmacol Ther. 1981 Aug;30(2):239-45
references.pmid: 7249508